Combination Therapy of Raloxifene and Alendronate for Treatment of Osteoporosis in Elderly Women

OBJECTIVES: To evaluate and compare the efficacy and safety of the combination of raloxifene and alendronate with those of monotherapies in elderly women with osteoporosis. METHODS: Sixty-two postmenopausal women (mean age 63.5 ± 0.5 years) attending gynecologic osteoporosis clinics with established...

Descripción completa

Detalles Bibliográficos
Autores principales: Um, Mi Jung, Cho, Eun A, Jung, Hyuk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Menopause 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432468/
https://www.ncbi.nlm.nih.gov/pubmed/28523260
http://dx.doi.org/10.6118/jmm.2017.23.1.56

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432468/
https://www.ncbi.nlm.nih.gov/pubmed/28523260
http://dx.doi.org/10.6118/jmm.2017.23.1.56

Ejemplares similares